Found 459 matching trials
Radiation Therapy in Unresectable Gall Bladder Cancer PHASE2 The goal of this clinical trial is to compare two treatment regimes, namely...
Show More Location
Tata Memorial Centre
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma PHASE3 This study will assess the efficacy and safety of mosunetuzumab in combinat...
Show More Status
Active Not Recruiting
Location
City of Hope Cancer Center
Learn More & Join Trial
mFOLFOX vs. mFOLFIRI in Advanced or Recurrent Biliary Tract Cancer Refractory to First Line PHASE2 In second line with advanced or recurrent biliary tract cancer refractory t...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
EndoTAG-1+GEM vs GEM in Patients With Locally Advanced/Metastatic Pancreatic Adenocarcinoma Failed on FOLFIRINOX PHASE3 The aim of this adaptive Phase 3 trial is to show a statistically significa...
Show More Location
Compassionate Cancer Care Medical Group, Inc
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial
NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer PHASE2 This phase II trial evaluates whether early switching from modified fluorou...
Show More Status
Active Not Recruiting
Location
OHSU Knight Cancer Institute
Learn More & Join Trial
Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to ASCT PHASE2 Multicentric phase II trial to evaluate efficacy and safety of ibrutinib in...
Show More Location
Hospital Universitario Son Espases
Learn More & Join Trial
QL1706 Combined With Lenvatinib and GEMOX as First - Line Treatment for Unresectable Biliary Tract Tumors PHASE2 QL1706 Combined with Lenvatinib and GEMOX as First - Line Treatment for Unr...
Show More Status
Active Not Recruiting
Location
the Third Affiliated Hospital of Naval Medical University
Learn More & Join Trial
Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer PHASE3 RATIONALE: Drugs used in chemotherapy such as gemcitabine and oxaliplatin u...
Show More Location
Comprehensive Cancer Institute
Learn More & Join Trial